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The genetically determined resistance ofinbred mouse strains to lethal infection
with murine cytomegalovirus (MCMV)' is under multigenic control and is deter-
mined by both H-2 and non-H-2 genes (1, 2). Mouse strains bearing the H-2k
haplotype are 10 times more resistant to MCMV infection than are congenic mouse
strains bearing the H-2b or H-2d haplotypes. In addition, increased resistance is as-
sociated with non-H-2 or background genes in the C57BL/6, C3H/Hej, and CBA/
CaH inbred mouse strains (2). Although the mechanisms of resistance to MCMV
infection are not fully understood, the death of mice of susceptible strains by 3 d
postinfection suggests that they must be effective early. In vitro infection studies have
shown that the level of MCMV infection of isolated cells from a range of murine
tissues reflects the patterns ofH-2 determinedresistance observed in vivo (3-5). These
results suggest that the H-2-associated resistance observed during infection may operate
at the level of individual target cells.
Although the number and chromosomal location ofnon-H-2 genes associated with
resistance to MCMV is unknown, they have been shown to exert their influence
early during MCMV infection by regulating the nonadaptive host responses medi-
ated by interferon (6-9), NK cells (10-13), and inflammatory cells (14). Non-H-2
genes have also been shownto regulate the amount of MCMV replication in critical
murine target organs after intraperitoneal infection (15). MCMV infection ofstrains
with the C57BL background [C57BL/6(H-2b) and B10.BR(H-2k)] resulted in very
low levels of splenic virus replication relative to H-2 identical strains with the BALB/c
background [BALB.B(H-2b) and BALB.K(H-2k)] . However, H-2 genes can also
regulate MCMV replication in the spleen, since resistant BALB.K(H-2k) mice ex-
hibit lower levels of splenic virus replication and clear virus more rapidly than do
the susceptible congenic BALB/c(H-2d) and BALB.B(H-2b) mouse strains (15, 16).
The latter H-2d and H-2b strains both exhibit similar high levels of splenic virus
replication.
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The primary aim of the present study was to determine the genetic basis of the
non-H-2 component of control of splenic replication of MCMV that is associated
with the C57BL background. Investigations using F, and FZ hybrids, backcross
mice, and the CXB set of recombinant inbred (RI) mouse strains indicate the oper-
ation of an autosomal dominant non-H-2 gene to which we assign the symbol Cmv-1.
Non-H-2 genes also influence host susceptibility to infection with HSV1 and the
C57BL background is associated with greatest resistance (17, 18). HSV1 replicates
initially in the skin from where it invades the sensory nervous system. Using a mu-
rine model of acute herpes simplex that closely mimics human disease (19), we re-
cently showed that resistance to neural infection, after cutaneous inoculation with
virus, is under complex host genetic control, involving up to four independently
segregating non-H-2 genetic loci (20). Initial control of HSV1 may be mediated
in part by interferons (21, 22) and NK cells(23), both ofwhich have been implicated
in resistance to MCMV infection (6-13). It is therefore possible that common genes
are involved in determining susceptibility to these herpesviruses, despite the dis-
similarities in their organ tropism. Because the C57BL background conveys early
acting resistance to the replication of both MCMV and HSV in their major target
organs, we investigated the hypothesis that Cmv-1 alleles are involved in resistance
to herpes simplex virus. Using the CXB RI mouse strains we confirmed the mul-
tifactorial nature of host resistance to HSV1, and showed that Cmv-1 is unlikely to
be involved.
Materials and Methods
Mice. 8-wk-old female mice, bred under specific pathogen-free conditions, were obtained
from the Animal Resources Centre (Murdoch, Western Australia) and housed under min-
imal disease conditions. Mice used in this study were the inbred strains A/J, BALB/cLac,
BALB/cBy, BALB.B, BALB.K, C57BL/6J, C57BL/6By, B10.A, B10.BR, B10.D2, CBA/CaH,
DBA/1J, DBA/2J, SJL/J, the F, generation (BALB/c x C57BL/6)F,, the backcross genera-
tions (BALB/c x C57BL/6)F, x BALB/c and (BALB/c x C57BL/6)F, x C57BL/6, the Fz
generation (BALB/c x C57BL/6)F, x (BALB/c x C57BL/6)F,, and the CXB/By recom-
binant inbred (RI) strains CXBD/By, CXBE/By, CXBG/By, CXBH/By, CXBI/By, CXBJ/By,
and CXBK/By. The BALB/cBy and C57BL/6By strains were only used in experiments that
involved the CXB/By RI strains. The CXB/By RI strains and the progenitor BALB/cBy and
C57BL/6By were originally obtained from The Jackson Laboratory, Bar Harbor, ME.
Virus.
￿
The Smith strain of MCMV, originally obtained from Dr. D. Lang (Duke Univer-
sity, Durham, NC), was used in all experiments. The method of maintenance of this stock
by salivary gland passage in weanling female BALB/c mice has been described elsewhere
(15) . Virus stocks were stored in the gas phase of liquid nitrogen and were regularly moni-
tored to exclude contamination with other infectious agents.
For HSV1 experiments, a well-characterized oral isolate, strain SC16, was used (24) . The
virus stock was grown and titrated in Vero cells and stored at -70°C until required.
Cell Culture.
￿
Primary mouse embryo fibroblast (MEF) cultures were prepared by trypsin
dispersion of 14-15-d-old embryos from outbred Arc Swiss mice by the method described
previously (1). MEFs and Vero cells were cultured in Eagle's MEM (Gibco Laboratories,
Grand Island, NY) and 10% FCS. Maintenance medium contained 2% FCS.
Infection ofMice.
￿
Mice were inoculated with MCMV by the intraperitoneal route with
0.1 ml of salivary gland-derived virus diluted in PBS (333 mosM) and containing 0.5 ,70 FCS.
The minimum intraperitoneal dose that killed 50% of animals inoculated (LD5o) was calcu-
lated using the Kaerber equation asdescribed elsewhere (2). Five mice per group were inocu-
lated over a range of serial twofold dilutions of MCMV giving from 0 to 100% mortality.SCALZO ET AL.
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A zosteriform model of HSVl infection was used in which mice were infected with 5 x
104 PFU of virus by scarification of the left flank as described previously (19).
Sample Collection.
￿
Organs to be titrated for MCMV or HSV1 by plaque assay were asep-
tically harvested, weighed, and then individually homogenized at 10 % wt/vol in ice cold MEM
containing 2% FCS, using chilled 2-ml Pyrextissue grinders (Corning, NY). After clarification
by centrifugation at 2,000 g for 20 min at 4°C, the supernatants were stored at - 70°C untiluse.
Virus Titrations: (i) MCMVPlaque Assay.
￿
The method used was a modification of that de-
scribed previously (1). Briefly, secondary MEF cultures were seeded into the wells of 24-well
tissue culture trays (Costar, Cambridge, MA) at 2 x 105 cells/well in MEM containing 10%
FCS 48 h before virus assay. Confluent monolayers were washed with 1 ml of maintenance
medium and 0.2 ml volumes of serial twofold dilutions of organ homogenates prepared in
maintenance medium were added to the wells. After incubating for 1 h at 37°C in 10% C02
in air, virus inocula were removed, and replaced with 2 ml of2% wt/vol methylcellulose (Fisher
Scientific, Fairlawn, NJ) in maintenance medium . Infected cultures were incubated for 5 d
at 37°C in 10% C02 in air and then stained with 1% methylene blue containing 10°70
formalin.
(ii) HSVPlaqueAssay.
￿
Serial 10-fold dilutions of tissue homogenates were tested for infec-
tivity in Vero cells using a standard plaque assay (25).
(iii) Infectious Center Assay.
￿
Productively infected cells present in the spleens of MCMV
infected mice were quantitated by an infectious center assay based on the method ofWinkler
and Booss (26). Briefly, single cell suspensions of spleens prepared as previously described
(27) were adjusted to 106 cells/ml and serial twofold dilutions were prepared in 0.5 ml
volumes of maintenance medium in 24-well tissue culture trays. The trays were incubated
for 1 h at 37°C in 10% C02 in air, the supernatant was then aspirated and 2 x 105 sec-
ondary MEFs in 1 ml maintenance medium were added to each well. After incubation for
1 h at 37°C in 10% C02 in air, the supernatant was aspirated and replaced with 2 ml of
2% methylcellulose in maintenance medium. Trays were then incubated for a further 5 d
before staining with 1% methylene blue containing 10% formalin.
Statistical Analysis.
￿
Where appropriate, comparisons of virus titers or LD50 titers between
strains were performed using Student's t-test. The patterns of segregation of parental pheno-
types in backcross and F2 mice were analyzed using the X2 test and nonparametrically using
the Kolmogorof Smirnofftest (28, 29). The relationship between splenic virus titers and spleen
weight was analyzed nonparametrically using the Spearman rank correlation test (30).
Results
Restricted Replication ofMCMV in the Spleens of (BALBIc x C57BL/6)Fl Mice.
￿
We
have previously shown that inbred mouse strains with C57BL background genes
(C57BL/6, H-2b; B10.BR, H-2k) support significantly lower levels of MCMV repli-
cation in their spleens than do H-2 syngeneic mouse strains with the BALB/c back-
ground (BALB.B, H-2b ; BAL&K, H-2k) (15). To further assess the genetic basis
for this non-H-2-determined control of splenic virus replication, the replication of
MCMV in the spleens of (BALB/c x C57BL/6)F, hybrid, BALB/c, and C57BL/6
mice was compared. All mice were inoculated by the intraperitoneal route with a
dose of virus that was sublethal for BALB/c mice (2.0 x 104 PFU, a 0.3 LD5o dose
for BALM). Relative to the parental BALB/c strain the level of MCMV replication
in the spleens of (BALB/c x C57BL/6)Fi hybrid mice was very low like that ob-
served for the parental C57BL/6 strain (Fig. 1 A). In contrast to the spleen the levels
of MCMV replication in the livers of the two parental strains and the F, hybrid
mice were all similar (Fig. 1 B). In contrast to marked differences in the splenic
MCMV titers between BALB/c and C57BL/6 mice, only very small differences in
spleen titers were observed between male and female mice of each strain (data not1472 GENETIC CONTROL OF SPLENIC CYTOMEGALOVIRUS REPLICATION
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FIGURE 1.
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Replication of MCMV in
thespleens(A)andlivers (B)ofBALB/c
("), C57BL/6 (/), and (BALB/c x
C57BL/6)FI hybrid (A) mice. Mice
were inoculated by theintraperitoneal
route with 2.0 x 104 PFU (0.3 LD5o
dose for BALB/c) of MCMV. Each
pointrepresentsthemean titer t SEM
of virus present in organs from three
individual mice. Thelimitofsensitivity
oftheplaque assaywas20 PFU/organ.
shown). Taken together, these results indicate that the restriction in splenic replica-
tion associated with the C57BL background is an autosomal dominant trait and
does notextend to theliver, whichis the othermajortarget organ during acuteMCMV
infection.
Enumerationofthe Genes ResponsibleforRestrictedSplenicReplicationofMCMVinC57BL/6
Mice: (i)BackcrossStudy. The number ofgenes involved in mediatingthe restriction
of MCMV replication in the spleens of C57BL/6 mice was investigated by deter-
mining the pattern of segregation of high and low levels of MCMV replication in
the spleens of (BALB/c x C57BL/6)FI x BALB/c backcross mice. Splenic titers in
the backcross progeny mice at day 4 postinfection, the day of peak splenic replica-
tion, segregated into distinct groups (Fig. 2) and were either BALB/c-like (24 of
53 with titers >10' PFU/spleen, 45.3%), or C57BL/6-like (29 of 53 with titers <10'
PFU/spleen, 54.7%). This distribution, which is not significantly different from a
1 :1 ratio (XZ = 0.472, p <0.5), suggests the operation of a single dominant gene
mediating the restriction in splenic MCMV replication during acute infection of
C57BL/6 mice (legend, Fig. 2).
A comparison of the distribution of splenic virus titers and spleen weights in in-
dividual mice within the (BALB/c x C57BL/6)FI x BALB/c backcross population
reveals that an inversecorrelation exists betweenthese two variables (Spearman rankW
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Genetic analysis of MCMV
replication in the spleens of backcross
generation mice. Mice were inoculated
by theintraperitonealroute with 3.2 x
104PFU (0.5 LD5o dose for BALB/c)
of MCMV andspleensremovedat day
4 afterinfection. Essentially identical
results were obtained in a separate re-
peat experiment. Analysis ofthecumu-
lative frequencydistribution ofspleen
titerin the(BALB/c x C57BL/6)FI x
BALB/c backcross mice relative to the
combined cumulative frequency of
spleen titers in the parental BALB/c
andC57BL/6mice usingthenonpara-
metric Kolmogoroff-Smirnoffstatistic
as previously described (28, 29), re-
vealed that Dm~(0.1641) was less than
thecritical tabulatedvalueat a = 0.05
(0.1831 for n = 53). On this basis the
hypothesis of control by a single gene
would not be rejected.
correlation coefficient, Ys = -0.855, corrected for tied data) (Fig. 3). Backcross mice
with low levels of virus replication (<104 PFU/spleen) had higher spleen weights
(mean t SEM = 0.124 t 0.004 g), which were comparable to those seen in in-
fected C57BL/6 parental mice (0.149 t 0.003 g). Conversely, mice with high levels
of virus replication (>104 PFU/spleen) had low spleen weights (0.072 t 0.002 g),
which were comparable with thoseofinfected BALB/c parental mice (0.086 t 0.003 g).
(ii) F2 Study.
￿
To corroborate the conclusion that the restricted splenic MCMV
replication associated with the C57BL/6 background is underunigenic control, the
pattern of splenic virus replication in the F2 progeny ofa (BALB/c x C57BL/6)Ft x
(BALB/c x C57BL/6)Fi mating was assessed. Fig. 4 shows that 25 of 101 (24.8%)
F2 progeny had high splenic virus titers (>104 PFU/spleen), while 76 of 101 (75.2%)
had low titers (104 PFU/spleen). This distribution, which is not significantly dif-
ferent from a 1:3 ratio (X2 = 0.0033, Ib <0.9), is consistent with the Mendelian
segregation of a single dominant gene (legend, Fig. 4). Basedon therules andguidelines
for standardized gene nomenclature (31), we propose to assign the symbol Cmv-1,
to the non-H-2 gene which restricts splenic replication of MCMV Accordingly,
BALB/c mice would be designated Cmv-1' and C57BL/6 mice would be designated
Cmv-11.
As observed above for the (BALB/c x C57BL/6)Fi x BALB/c backcross mice,1474 GENETIC CONTROL OF SPLENIC CYTOMEGALOVIRUS REPLICATION
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Splenicvirustiters and
spleen weights in MCMV infected
(BALB/c x C57BL/6)FI x BALB/c
backcross mice. This figure shows
a scatter plot of splenic virus titers
versus spleen weights for the in-
dividual (BALB/c x C57BL/6)
F, x BALB/c backcross mice rep-
resented in Fig. 2. The mean t
SEMof spleenweights ofbackcross
mice with splenic virus titers >101
PFU/spleen was 0.072 t 0.002 g
and for mice with titers <104 PFU/
spleen was0.124 t 0.004 g. In the
parental strains themean t SEM
ofspleen weights were forBALB/c
(uninfected, 0.091 t 0.003 g; in-
fected, 0.086 f 0.003 g) and for
C57BL/6 (uninfected, 0.084 t
0.007 g; infected 0.149 ± 0.003 g).
spleen weights in individual MCMVinfected F2 mice also reflected splenic virus
titers. Mice with low splenic virus titers (<104 PFU/spleen) had higher spleen
weights (0.141 t 0.003 g, n = 76), compared with a mean weight of 0.074 t 0.004
g (n = 25) in mice that had high spleen titers (>104 PFU/spleen).
ChromosomalLocation ofthe Cma-1 Gene.
￿
To determinethe geneticlinkage and chro-
mosomal location of Cma-1, the level of splenic MCMV replication in the CXB/By
set of recombinant inbred mice was assessed . Fig. 5 A shows that all seven CXB/By
RI mouse strains clearly segregate into one or other of the progenitor strain pat-
terns. The CXBD/By, CXBE/By, and CXBJ/ByRI strains exhibited very low spleen
titers, like the C57BL/6By progenitor strain, whereas the CXBG/By, CXBH/By,
CXBI/By, and CXBK/By RI strains were all BALB/cBy-like, exhibiting high spleen
titers that peaked at >10' PFU/spleen at day 4 postinfection. This strain distribu-
tion pattern (SDP) was reflected in an identical SDP for the numbers of infected
splenic cells at day 2 after infection, as determined by infectious center plaque assay
(Table I). In contrast to the spleen, the virus titers present in the livers of the CXB
RI strains showed less variation, and did notclearly segregate into progenitor strain
patterns (Fig. 5B). The CXBKBy strain differed from all the otherstrainsby failing
to show clearance of virus in the liver at day 6 after infection.
The clear-cut SDP of the Cma-1' (C57BL/6-like) and Cma-1' (BALB/c-like) alleles2
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FIGURE 4. Genetic analysis of
MCMV replication in thespleens
of F2 generation mice. Mice were
inoculated by the intraperitoneal
route with 3.2 x 104 PFU (0.5
LD5o dose for BALB/c) ofMCMV
and spleens were removed at day
4 afterinfection. Comparison ofthe
cumulative frequencydistribution
of the F2 spleen titers with the
combined frequency distribution of
the parental strains (3/4 of cumu-
lative frequencyofC57BL/6 + 1/4
ofcumulative frequencyofBALB/
c) usingthe Kolmogorofl=Smirnoff
statistic (28, 29), reveals that the
value of Dman (0.1080) was less
than the critical valueat a = 0.05
(0.1334, for n = 101).
amongthe sevenCXB RI strains permittedcomparison withthe SDPsofother genes
in these mice. Thepattern was identical onlyto thatoftheproline-rich protein (Prp)
and erythrocyte alloantigen-10 (Ea-10) genes (Table II), which are linked on chro-
mosome 6 (32). The pattern showed that the Cmu-1 gene was not located within the
H-2 complex. Although the available evidence suggests that Cmu-1 is linked to Prp
and Ea-10 on chromosome 6, a more detailed analysis in a larger set ofRI strains
is required, and this is in progress.
HSV1 Replication in the Ganglia ofthe CXB Recombinant Inbred Mouse Strains.
￿
Repli-
cation ofHSV1 in the sensory ganglia ofCXB mice was examined 2 and 3 d after
cutaneous inoculationwithvirus(Fig. 6). Theprogenitor strains were clearlydistin-
guishable and most recombinantinbred strains were ofan intermediate phenotype.
However, CXBD/By andCXBG/Bymice segregatedwith the C57BL/6By progenitor.
ResistanceofCXB Recombinant InbredMouseStrains to LethalMCMVInfection.
￿
Previous
studies have shown that mouse strains possessingtheC57BLbackground are reprodu-
ciblyabout four timesmore resistant to lethal infection with MCMV than aremice
with the BALB background (1, 2). To investigate if the low levels of splenic virus
replication seen inthe CXBD/By, CXBE/By, andCXBJ/By RI strainsare associated1476 GENETIC CONTROL OF SPLENIC CYTOMEGALOVIRUS REPLICATION
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￿
Genetic analysis of MCMV replication in the spleens (A) and livers (B) ofthe CXB
recombinant inbred mouse strains. Mice were inoculated by the intraperitoneal route with 2.0 x
104 PFU (0.3 LDso dose for BALB/c) of MCMV and organs were removed at the times indi-
cated. Each point represents the mean ± SEM of virus titers from eight individual animals.
with enhanced resistance, the relative resistance status of each of the CXB RI mouse
strains was determined . Table III shows the mean LD50 values from three separate
experiments. TheCXBG/By, CXBH/By, CXBI/By, and CXBK/By RI strains were
at least as susceptible to lethal MCMV infection as theprogenitor BALB/cBy strain.
In contrast, the CXBD/By, CXBE/By, and CXBJ/By RI strains were allsignificantly
more resistant than the BALB/cBy mouse strain (p <0.025, p <0.025,p<0.01, respec-
tively), but not as resistant as the progenitor C57BL/6Bystrain. This pattern resembles
TABLE I
Numbers of MCMV-infected Spleen Cells after Acute Sublethal
Infection of CXB RI Strains
Numbers of infected
Mouse strain
￿
cells/spleen"
BALB/cBy
￿
20,830
C57BL/6By
￿
<110
CXBD/By
￿
<70
CXBE/By
￿
210
CXBG/By
￿
36,290
CXBH/By
￿
8,230
CXBI/By
￿
7,070
CXBJ/By ￿420
CXBK/By
￿
34,960
" Pooled spleen cell suspensions were prepared from groups of three mice per
strain infected 2 d previously by the intraperitoneal route with 2 .5 x 104 PFU
of MCMV. The numbers of infected splenocytes were quantitated by infec-
tious center plaque assay.SCALZO ET AL.
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TABLE II
Concordance of the SDPs of Cmv-1 and Chromosome 6 Markers
in the CXB/By Recombinant Inbred Strains
" The generic symbols B and C are used here to indicate alleles inherited from
the progenitor strains C57BL/6By and BALB/cBy, respectively (33).
1 Reference 32.
S Reference 33 .
thestrain distribution patternobserved forregulationofsplenic MCMV replication
by the Cmv-1 gene in the CXB RI strains. These results suggest that the low levels
of splenic MCMV replication associated with the Cmv-I' allele may in part be
responsible for the enhanced resistance to lethal MCMV infection seen in mouse
strains with the C57BL genetic background.
Comparison ofSplenicMCMVReplication in aRangeofInbredMouseStrains.
￿
Todeter-
mine ifthe restriction in splenic MCMV replication observed in mouse strains with
the C57BL background was acharacteristicofother genetic backgrounds, the ability
ofMCMV to replicate in the spleens ofa range ofmouse strains was investigated.
Mice were infected with alow dose (4 x 104 PFU; sublethal for BALB/c) or a high
dose (4 x 105 PFU; lethal for BALB/c and C57BL/6) and spleens were harvested
at early time points (day 2 after infection, Exp. 1; day 3 after infection, Exp. 2).
TABLE III
lative
D50S
1 .0
5.0
3.3
2.5
0.5
1 .2
0.9
CXBD/By ￿18 .0 f 2 .8
￿
0.005 < p < 0.01
￿
2.8
CXBK/By
￿
2 .7 t 0.2
￿
p 4 0.0005
￿
0.4
" Groups of five mice per dilution received serial twofold dilutions of MCMV
by the intraperitoneal route. The results represent the means t SEM ofthree
separate determinations.'
1 The differences in the LD50 titers of the CXB/By RI strains and the
C57BL/6By strain from the BALB/cBy strain were statistically analyzed by
Student's nest .
S Relative LD50 refers to the ratio ofthe LD5o dose for a particular strain rela-
tive to that of BALB/cBy.
CXB RI strains
Locus Chromosome D E G H I J K
Cmv-1 B' B C" C C B C
Prp1 6 B B C C C B C
Ea-101 6 B B C C C B C
H-25 17 C B B C B B B
Relative Susceptibility of CXB Recombinant Inbred Mouse Strains
to Lethal Infection with MCMV
Mean LD50 dose t SEM R
Mouse strain (PFU x 10-4)` p Valuel
BALB/cBy 6 .4 t 0.1
C57BL/6By 31 .7 t 5.0 0.0005 < p < 0.005
CXBD/By 21 .3 t 4.6 0.01 < p < 0.025
CXBE/By 16.0 t 3.2 0.01 < p < 0.025
CXBG/By 3 .3 t 0 .8 0.005 < p < 0.01
CXBH/By 7 .4 t 1 .4 0.1 < p < 0.375
CXBI/By 6.0 t 0.7 0.1 < p < 0.3751478 GENETIC CONTROL OF SPLENIC CYTOMEGALOVIRUS REPLICATION
Table IV shows that all mouse strains, except those with the C57BL background,
gave elevated levels ofsplenic virus replication when inoculated with 4 x 104 PFU
of MCMV. When the virus dose was increased to 4 x 105 PFU even mice of the
C57BL background exhibited moderately elevated titers, although these were still
significantly less (p <0.005) than those obtained from the H-2 syngeneic BALBX
(H-2k) and BALB.B (H-2b) strains (Table IV, Exp. 1).
Discussion
Classical Mendelian analyses with backcross and F2 progeny derived from
BALB/c (susceptible) and C57BL/6 (resistant) progenitor strains disclosed an au-
tosomal genetic locus that controls splenic replication ofMCMV At this locus, to
which we have assigned the symbol Cmv-1, alleles conveying resistance are domi-
nant. The concordance, in CXB RI mice, between the SDP's of Cmv-1, Prp, and
Ea40 suggests that Cmv-1 may be located on mouse chromosome 6.
The Cmv-I' allele associated with C57BL mice is not present in the A, BALB,
CBA, DBA/1, DBA/2, or SJL genetic backgrounds (Table IV). However, the inter-
mediate titers obtained for theCBA/CaH, DBA/2J andSJL/J strains donot permit
a Cmv-I' genotype to be ascribed to these strains and a more extensive kinetic anal-
ysis is required to determine if these strains possess Cmv-1 alleles that exert inter-
mediate control ofvirus replication, or whetherothernon-H-2 genes also modulate
the level of splenic MCMV replication. At the higher dose of 4 x 105 PFU the
B10.BR (H-2k) and C57BL/6J (H-2n) strains also showed elevated MCMV titers
TABLE IV
Splenic MCMV Replication in a Range of Inbred Mouse Strains
` In both experiments groups of four mice per strain received intraperitoneal
inoculations of the appropriate dose of MCMV. Spleens were taken at day 2
(Exp. 1) or day 3 after infection (Exp. 2) for assay of virus titers.
t ND, not done.
Exp.
Mouse
strain
H-2
haplotype
Splenic MCMV titer
(mean PFU/spleen t SEM)
in mice inoculated with:
Low dose High dose
(4 x 104 PFU) (4 x 105 PFU)
1' BALB.13 H-2n 14,170 t 830 186,880 t 30,520
C57BL/6J H-26 60 t 25 3,310 t 1,245
BALB.K H-2k 8,950 t 1,250 133,760 t 33,820
1310.13R H-2k <20 11,980 t 745
CBA/CaH H-2k 2,320 t 390 51,305 t 10,835
2' A/J H-2a 27,510 t 3,750 ND1
1310.A H-2a 55 t 30 ND
BALB/c H-2d 24,890 t 3,930 ND
DBA/2J H-2d 10,090 t 1,730 ND
1310 .132 H-2d <20 ND
BALB.B H-26 39,105 t 5,010 ND
C57BL/6J H-26 90 t 35 ND
BALB.K H-2k 7,180 t 2,250 ND
DBA/1J H-29 20,130 t 2,990 ND
SJL/J H-29 6,700 t 1,730 NDSCALZO ET AL.
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(Table IV, Exp. 1). This confirms previous results ofAllan and Shellam (15) and
indicates that the operation of Cmv-1 can be overridden by increasing the virus in-
oculum.
The Cmv-1 locus may substantially influence overall survival of the animal be-
cause mouse strains that exhibited low levels of splenic MCMV replication were
significantly more resistant to lethal infection (Table III). Two additional observa-
tions support this hypothesis. Firstly, Katzenstein et al., (34) showed that splenec-
tomy conferred resistance to BALB/c mice implying that replication ofvirus in this
organ contributed significantly to death. Second, preliminary studies have shown
thatthe Cmv-1 locusmayalso regulatethelevel ofinvivoinfection in thebonemarrow
and thereby influence thedegree ofbonemarrowsuppression associated with MCMV
infection (Gibbons, A. E., A. A. Scalzo, P Price, and G. R. Shellam; unpublished
observations). Indeed Bale et al. (35), showed that peak replication of MCMV in
bone marrow and spleens ofoutbred Swiss mice was concurrent and coincidedwith
leukopenia.
Nevertheless resistance tolethal infection cannot be influenced exclusivelyby Cmv-1
because some RI strains(CXBG/Byand CXBK/By) showed enhancedsusceptibility
compared with BALB/cBy, while others (CXBD/By, CXBEBy, and CXBJ/By)were
intermediate in relation to the progenitor strains. In this context it is interesting
to note that the effect of the Cmv-1 locus is not manifested in the liver.
ThemechanismbywhichtheC57BL/6 Cmv-1 allele conveys resistance is unknown,
but several points are worthy ofdiscussion. In (BALB/c x C57BL/6)Fl x BALB/c
backcrossprogeny, high splenic virus titers were associated with low spleen weight.
This observation extends the findings of Mims and Gould (36) who showed that
MCMVinfected BALB/c andA strain mice developed splenic atrophy and necrosis
in association with a high level ofvirus replication. In contrast, low splenic virus
titers were accompanied by splenomegaly thatcould be the result either ofan influx
ofleukocytes from otherlymphoid organs ortheproliferation ofcells already present
within the spleen (Fig. 3). It is tempting to speculate that the as yet unidentified
product ofCmv-1 determines the efficacy ofthis early inflammatory response. Cer-
tainly the resistance conferred by the C57BL/6 allele is manifest early in the course
ofthe disease, because restriction ofsplenic replication is evident 1-2 d after infec-
tion (Figs. 1 A and 5 A). This aspect, including the potential involvement of inter-
feron and NK cells, is a focus of continuing work.
For both MCMV and HSV1 similarities in the hierarchy ofresistance exist, such
that mice with theC57BL background show greater resistance relative to mice with
the BALB background, although this effect is much more pronounced for HSV1
(2, 17, 37). Indeed, C57BL/6mice survive an intraperitoneal challengewith >1,000
times the amount ofHSV1 tolerated by avariety ofotherinbred strains (17). After
cutaneous inoculation, restriction ofthe infection by resistant mice occurs primarily
in the sensory nervous system (38). In thepresent study, at 2 and 3 d after infection
of the flank skin, C57BL/6 and BALB/c progenitor mice could be clearly distin-
guished in terms ofvirus recovery from spinal ganglia(Fig. 6). Most CXB RI strains
were intermediate in this respect suggesting that neural infection is under complex
genetic control, which is in concordance with previously reported F2 and backcross
studies (20). However, the behavior ofCXBG/By mice requires further comment.
This strain has the BALB/c allele at the Cmv-1 locus yet is completely resistant to1480
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FIGURE 6. Genetic analysis of
HSVreplication in theperipheral
nervous system of CXB recom-
binant inbred mousestrains. Mice
were inoculated cutaneously with
5 x 104 PFU of HSV1 and the
spinal ganglia were removedat the
timesindicated. Each point repre-
sents the mean t SEM of virus
titers from 5to 10 individual animals.
neural infection with HSV1. This strongly suggests that Cmv-1 is not involved in
the restriction of HSV1 infection, with the caveat that complementation between
unrecognized genes cannot be excluded as the cause ofCXBG/By resistance.
Two strategies will be valuable for the functional analysis ofthe Cmv-1 locus. First,
and most important, is the construction of a bilineal congenic strain in which the
C57BL/6 allele Cmv-I1 has been transferred to the BALB/c background. Second, lo-
calization of the gene may be of value. Its apparent association with chromosome
6 will be strengthened by determining the SDPs ofsplenic MCMV replication in
the AXB andBXD RI sets, which are derived fromA/J and C57BL/6J progenitors,
and C57BL/6J and DBA/2J progenitors, respectively. Both ofthese approaches are
underway in our laboratory. In addition, determination ofrecombination frequen-
cies in hybrid mice may be used to estimate the distance between Cmv-1 and genes
of known location such as Prp and Ly-2 (32, 39).
In conclusion, this study has identified a novel non-H-2 gene, designated Cmv-1,
which regulates MCMV replication in an organ-restricted manner and contributes
to host resistance to lethal MCMV infection.
Summary
The genetic basis of the control of acute splenic MCMV infection was studied
after intraperitoneal inoculation of the virus. Classical Mendelian analyses using
C57BL/6 (resistant) and BALB/c(susceptible) parental strainsdisclosed an autosomal
dominant non-H-2 gene that regulates splenic virus replication. The probable loca-
tion ofthis gene, to which we have assigned the symbol Cmv-1, is on chromosome
6 asdefinedby thestrain distribution pattern ofsplenicMCMV replicationinCXB
recombinant inbred mice.Although there is a similar hierarchy of resistance to MCMV and HSV1 with
respect to the C57BL and BALB genetic backgrounds, the strain distribution pat-
tern of HSV1 replication in recombinant inbred mice suggests that Cmv-1 is not
involved in restricting the spread of this virus.
This is the first clear identification of a non-H-2 gene regulating the magnitude
ofMCMV infection. Elucidation ofthe function ofthis gene may be a fundamental
step towards understanding the control of systemic CMV infection.
We are grateful to Dr. Benjamin Taylor of The Jackson Laboratory, Bar Harbor, Maine for
his advice on the SDP of Cmv-1 in CXB mice, to Dr. Edwin Azen, Department of Medicine
and Medical Genetics, University ofWisconsin, Madison for providing data prior to publi-
cation, to Mr. Andrew Wood for advice on statistical analysis, and to Drs. Patricia Price
and Helen Farrell for helpful discussions.
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